Vedana Therapeutics
Vedana Therapeutics is developing long-acting biologic medicines to prevent migraine by targeting PACAP and other pathways beyond CGRP. Its therapies are intended for people whose migraine is not adequately controlled by current treatments.
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology Research
- Employees
- 19
- Stage
- Series A
Is this your organization? Claim it
Members see Vedana Therapeutics's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Anurag Agarwal Founder & CEO
-
Leon Garcia Founder & CSO
-
Ernesto Aycardi Executive, CMO